Byrne Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | -$420K | – | 80 |
|
2025
Q1 | – | Hold |
0
| – | -$387K | – | 73 |
|
2024
Q4 | – | Sell |
-2,210
| Closed | -$436K | – | 72 |
|
2024
Q3 | $436K | Buy |
+2,210
| New | +$436K | 0.3% | 76 |
|
2024
Q2 | – | Hold |
0
| – | -$478K | – | 81 |
|
2024
Q1 | – | Sell |
-2,643
| Closed | -$409K | – | 73 |
|
2023
Q4 | $409K | Buy |
+2,643
| New | +$409K | 0.31% | 78 |
|
2023
Q3 | – | Sell |
-2,869
| Closed | -$387K | – | 70 |
|
2023
Q2 | $387K | Buy |
2,869
+210
| +8% | +$28.3K | 0.25% | 104 |
|
2023
Q1 | $424K | Buy |
2,659
+140
| +6% | +$22.3K | 0.3% | 93 |
|
2022
Q4 | $407K | Sell |
2,519
-625
| -20% | -$101K | 0.29% | 91 |
|
2022
Q3 | $422K | Buy |
3,144
+61
| +2% | +$8.19K | 0.33% | 89 |
|
2022
Q2 | $472K | Buy |
3,083
+25
| +0.8% | +$3.83K | 0.35% | 74 |
|
2022
Q1 | $496K | Buy |
3,058
+545
| +22% | +$88.4K | 0.31% | 76 |
|
2021
Q4 | $340K | Buy |
+2,513
| New | +$340K | 0.22% | 89 |
|